The global human recombinant insulin market is estimated to be valued at US$ 36,134.5 million in 2022 and is expected to exhibit a CAGR of 7.3% during the forecast period (2022-2030).
Figure 1. Global Human Recombinant Insulin Market Share (%), by Product Type, 2022
The increasing investment in diabetes research activities is expected to drive the growth of the global human recombinant insulin market.
Figure 2.Global Human Recombinant Insulin Market Share (%), by Region, 2022
Increasing prevalence of diabetes worldwide is expected to drive growth of the global human recombinant insulin market is expected to drive the market growth.
Increasing prevalence of diabetes worldwide is expected to drive growth of the human recombinant insulin market is expected to drive the market growth over the forecast period. For instance, according to data published by the World Health Organization (WHO) in 2019, diabetes was the direct cause of 1.5 million deaths and 48% of all deaths due to diabetes occurred before the age of 70 years.
Human Recombinant Insulin Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients